| Trial ID: | L6735 |
| Source ID: | NCT00708578
|
| Associated Drug: |
Glimepiride
|
| Title: |
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Glimepiride|DRUG: Metformin|DRUG: Insulin Glargine
|
| Outcome Measures: |
Primary: HbA1c values, At baseline to end of treatment | Secondary: Hypoglycemia events, From inclusion to end of study|Percentage of patients with HbA1c < 7%, At the end of the study|Fasting Blood Glucose level, At the end of the study
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
99
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2009-12
|
| Results First Posted: |
|
| Last Update Posted: |
2011-01-25
|
| Locations: |
Sanofi-Aventis Administrative Office, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00708578
|
